Achillion Pharmaceuticals

unknown
unknown
Stage

About

Achillion Pharmaceuticals is a pharmaceutical company developing treatments for challenging infectious diseases including hepatitis C and resistant bacterial infections. The company went public in 2006.

Explore Achillion Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.